These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 34562701

  • 1. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors.
    Li J, Jiang X, Dick A, Prakash Sharma P, Chen CH, Rathi B, Kang D, Wang Z, Ji X, Lee KH, Cocklin S, Liu X, Zhan P.
    Bioorg Med Chem; 2021 Oct 15; 48():116414. PubMed ID: 34562701
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
    Zhang X, Sun L, Meuser ME, Zalloum WA, Xu S, Huang T, Cherukupalli S, Jiang X, Ding X, Tao Y, Kang D, De Clercq E, Pannecouque C, Dick A, Cocklin S, Liu X, Zhan P.
    Eur J Med Chem; 2021 Dec 15; 226():113848. PubMed ID: 34592608
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
    Sun L, Huang T, Dick A, Meuser ME, Zalloum WA, Chen CH, Ding X, Gao P, Cocklin S, Lee KH, Zhan P, Liu X.
    Eur J Med Chem; 2020 Mar 15; 190():112085. PubMed ID: 32066010
    [Abstract] [Full Text] [Related]

  • 4. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
    Sun L, Dick A, Meuser ME, Huang T, Zalloum WA, Chen CH, Cherukupalli S, Xu S, Ding X, Gao P, Kang D, De Clercq E, Pannecouque C, Cocklin S, Lee KH, Liu X, Zhan P.
    J Med Chem; 2020 May 14; 63(9):4790-4810. PubMed ID: 32298111
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
    Xu S, Sun L, Dick A, Zalloum WA, Huang T, Meuser ME, Zhang X, Tao Y, Cherukupalli S, Ding D, Ding X, Gao S, Jiang X, Kang D, De Clercq E, Pannecouque C, Cocklin S, Liu X, Zhan P.
    Eur J Med Chem; 2022 Jan 05; 227():113903. PubMed ID: 34653770
    [Abstract] [Full Text] [Related]

  • 6. Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library.
    Wu G, Zalloum WA, Meuser ME, Jing L, Kang D, Chen CH, Tian Y, Zhang F, Cocklin S, Lee KH, Liu X, Zhan P.
    Eur J Med Chem; 2018 Oct 05; 158():478-492. PubMed ID: 30243152
    [Abstract] [Full Text] [Related]

  • 7. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L, Casey MC, Vernekar SKV, Do HT, Sahani RL, Kirby KA, Du H, Hachiya A, Zhang H, Tedbury PR, Xie J, Sarafianos SG, Wang Z.
    Eur J Med Chem; 2020 Aug 15; 200():112427. PubMed ID: 32438252
    [Abstract] [Full Text] [Related]

  • 8. Design, Synthesis and Structure-Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component Reaction.
    Ji X, Li J, Sharma PP, Jiang X, Rathi B, Gao Z, Hu L, Kang D, De Clercq E, Cocklin S, Liu C, Pannecouque C, Dick A, Liu X, Zhan P.
    Molecules; 2022 Sep 14; 27(18):. PubMed ID: 36144727
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74.
    Sahani RL, Diana-Rivero R, Vernekar SKV, Wang L, Du H, Zhang H, Castaner AE, Casey MC, Kirby KA, Tedbury PR, Xie J, Sarafianos SG, Wang Z.
    Viruses; 2021 Mar 15; 13(3):. PubMed ID: 33804121
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J, Zhou J, Shah VB, Aiken C, Whitby K.
    J Virol; 2011 Jan 15; 85(1):542-9. PubMed ID: 20962083
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E, Ablan SD, Mandt R, Pauly GT, Sigano DM, Schneider JP, Martin DE, Nitz TJ, Wild CT, Freed EO.
    Antimicrob Agents Chemother; 2016 Jan 15; 60(1):190-7. PubMed ID: 26482309
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors.
    Jiang X, Wu G, Zalloum WA, Meuser ME, Dick A, Sun L, Chen CH, Kang D, Jing L, Jia R, Cocklin S, Lee KH, Liu X, Zhan P.
    RSC Adv; 2019 Jan 15; 9(50):28961-28986. PubMed ID: 32089839
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein.
    Tian B, He M, Tang S, Hewlett I, Tan Z, Li J, Jin Y, Yang M.
    Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2162-7. PubMed ID: 19297155
    [Abstract] [Full Text] [Related]

  • 20. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
    Tsuji K, Wang R, Kobayakawa T, Owusu KB, Fujino M, Kaneko M, Yamamoto N, Murakami T, Tamamura H.
    Bioorg Med Chem; 2021 Jan 15; 30():115923. PubMed ID: 33316719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.